Safety and preliminary immunogenicity of the recombinant outer membrane protein P64k of Neisseria meningitidis in human volunteers.
Pérez A, Dickinson F, Cinza Z, Ruíz A, Serrano T, Sosa J, González S, Gutiérrez Y, Nazábal C, Gutiérrez O, Guzmán D, Díaz M, Delgado M, Caballero E, Sardiñas G, Alvarez A, Martín A, Guillén G, Silva R.
Pérez A, et al. Among authors: guillen g.
Biotechnol Appl Biochem. 2001 Oct;34(2):121-5. doi: 10.1042/ba20010029.
Biotechnol Appl Biochem. 2001.
PMID: 11592918
Clinical Trial.